Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
18
2021
Six Things You Need to Know About CBD and Other Hemp-containing Pet Products Womble Bond Dickinson (US) LLP
Aug
17
2021
Another Florida Mini-TCPA Class Action Filed – This Time Against Pizza Hut Troutman Amin, LLP
Aug
17
2021
PhRMA Updates its Code on Interactions with Health Care Professionals in Response to the OIG's Special Fraud Alert on Speaker Programs Mintz
Aug
17
2021
Pennsylvania Court Holds Medical Marijuana Act Allows Employees to Sue for Discrimination Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Aug
17
2021
New Vaccine Requirements for Federal Contractors Bradley Arant Boult Cummings LLP
Aug
17
2021
Taking Advantage of Medicare Advantage: Medicare Part C Fraud Tycko & Zavareei LLP
Aug
17
2021
Senate Bill Targets CA’s Animal Welfare Law Keller and Heckman LLP
Aug
17
2021
Marijuana Legalization Rundown: New Legislation Across Several States Epstein Becker & Green, P.C.
Aug
16
2021
Pennsylvania Appellate Court Affirms State Medical Marijuana Law Provides Private Right Of Action Jackson Lewis P.C.
Aug
16
2021
FDA Reaffirms Need for More Safety Data on CBD Keller and Heckman LLP
Aug
16
2021
Another Battle in the Political Fight Over How to Address High Drug Prices Mintz
Aug
13
2021
Running Down the Field of Sports Performance Drinks with Terrell Davis and Megan Bushell from DEFY [PODCAST] Greenberg Traurig, LLP
Aug
13
2021
EU Revises Lead and Cadmium Limits Keller and Heckman LLP
Aug
13
2021
EFSA Publishes Safety Assessment of Silver Nanoparticles Intended to Be Used in Plastics Bergeson & Campbell, P.C.
Aug
13
2021
5 Keys to Passing an FDA Inspection or Audit Oberheiden P.C.
Aug
13
2021
PhRMA Code Update Clarifies and Tightens Key Provisions Associated with Speaker Programs Foley & Lardner LLP
Aug
12
2021
New York and New Jersey Legalize Recreational Marijuana: Still, Immigrants Might Face Risks Norris McLaughlin P.A.
Aug
12
2021
The Rise and Fall of “Vanilla” Labeling Challenges Proskauer Rose LLP
Aug
12
2021
Legal Victory for “Vegan Butter” Keller and Heckman LLP
Aug
12
2021
The Skinny Label That Wasn’t—Federal Circuit Reinstates Induced Infringement Verdict McDermott Will & Emery
Aug
11
2021
“Champion” Petfoods: Seventh Circuit Affirms Dismissal of False Advertising Suit Against Pet Food Company Proskauer Rose LLP
Aug
11
2021
California Amends Olive Oil Labeling Bill Keller and Heckman LLP
Aug
10
2021
Consumers Allegedly Deceived by Sugar Claims Keller and Heckman LLP
Aug
10
2021
CMS Proposes to Rescind Most Favored Nation Drug Pricing Rule K&L Gates
Aug
10
2021
Let it “Bee”: Ninth Circuit Affirms Dismissal of Trader Joe’s Manuka Honey Advertising Suit Proskauer Rose LLP
Aug
10
2021
The Hot Coffee Case Revisited: Has Proximate Cause Changed in the 25 Years Since Liebeck v. McDonald’s Restaurants? ArentFox Schiff LLP
Aug
10
2021
Securities Litigation Update: First Circuit Holds That Future-Focused Risk Disclosures Are Not Misleading Absent “Grand Canyon”-Level Threat to Company Cadwalader, Wickersham & Taft LLP
Aug
9
2021
House Bill Would Require FDA to Study and Reassess Chemicals Used in Food Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins